Is a third SARS-CoV-2 vaccine dose efficient in allogeneic haematopoietic cell transplant recipients?
Br J Haematol
; 201(1): 9-10, 2023 04.
Article
in English
| MEDLINE | ID: covidwho-2282328
ABSTRACT
When and how often should allogeneic haematopoietic cell transplantation recipients be vaccinated against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is unclear. The report by Bankova et al. suggests that a third SARS-CoV-2 vaccine dose is important but still insufficient in some patients to establish an adequate humoral response. Commentary on Bankova et al. Antibody response to a third SARS-CoV-2 vaccine dose in recipients of an allogeneic hematopoietic cell transplantation. Br J Haematol. 2023;20158-63.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
COVID-19
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Br J Haematol
Year:
2023
Document Type:
Article
Affiliation country:
Bjh.18591
Similar
MEDLINE
...
LILACS
LIS